Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hercules Technology Growth Capital (NY: HTGC )

18.25 +0.09 (+0.50%)
Official Closing Price Updated: 4:10 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hercules Technology Growth Capital

< Previous 1 2 3 Next >
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?
Stocks that work for billionaires aren't necessarily appropriate for every investor. 
Via The Motley Fool
Here Are My Top 3 Ultra-High-Yield Dividend Stocks to Buy in April
Investors looking for some reliable growth may want to consider three ultra-high-yield business development companies. 
Via The Motley Fool
Analyst Ratings For Hercules Capital
Via Benzinga
The Cash Cow Cavalry: 3 Stocks Leading the Charge to Profitability
Profitability drives a company's value in the market. These three stocks are headed toward stellar margins and profit growth! 
Via InvestorPlace
Why Bluebird Bio Stock Flew Higher Than the Market Today
The company was thrown a financial lifeline. 
Via The Motley Fool
Investing $50,000 Into These Ultra-High-Yield Dividend Stocks Could Make You Nearly $5,200 in Annual Income
Business development companies (BDCs) can be a lucrative source of passive income because of their unique business structure. 
Via The Motley Fool
Why NYSE:HTGC is a Top Pick for Dividend Investors.
Is HERCULES CAPITAL INC (NYSE:HTGC) a Good Fit for Dividend Investing? 
Via Chartmill
Hercules Capital's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Via Benzinga
Key Takeaways From Hercules Capital Analyst Ratings
Via Benzinga
Here Are My Top 10 Ultra-High-Yield Dividend Stocks to Buy in 2024
These 10 companies offer exposure to many different sectors, while providing steady passive income. 
Via The Motley Fool
Want to Make $10,000 in Passive Income This Year? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks.
Business development companies (BDCs) can be lucrative opportunities for investors seeking dividend income. 
Via The Motley Fool
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Earnings Preview For Hercules Capital
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss Hercules Capital Stock
Via Benzinga
General Motors, Hercules Capital, Toast And More: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named Hercules Capital, Inc. (NYSE: HTGC) as her 
Via Benzinga
Don’t Forget BDCs For Stable, High-Yield Income
The Fed’s aggressive interest rate increases have been good for business development companies. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Where Hercules Capital Stands With Analysts
Via Benzinga
Why You Need To Be Buying BDCs Right Now
Via Talk Markets
Investing $100,000 in These 3 Ultra-High-Yield Dividend Stocks Could Bring $10,000 in Passive Income to Your Portfolio in 2024
Business development companies are a lucrative way to generate loads of passive income. 
Via The Motley Fool
PINES And QUIBS And PDs, Oh My - Minibonds Anyone?
Have you ever considered Minibonds for an income portfolio or your retirement plan? These are bonds that are traded just like stocks on the New York Stock Exchange, American Stock Exchange, or Nasdaq... 
Via Talk Markets
Topics Bonds Retirement
Exposures Debt Markets Pension
1 Ultra-High Dividend Yield Stock to Buy Hand Over Fist in 2024
Ares Capital has handily beaten the S&P 500 for several years. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
This Dividend Stock Has Returned 157% Over the Past 10 Years. You Can Buy It Today for Just $15
Hercules Technology Growth Capital makes high-yield loans to energy, life sciences, and technology businesses. 
Via The Motley Fool
You Can Buy All 4 of These Ultra-High Yield Dividend Stocks for Less Than $100
Looking for passive income? These stocks have proven track records of paying consistent dividends. 
Via The Motley Fool
This Ultra-High Dividend Stock Pays You Almost 12% to Own It. It Can Be Yours For Less Than $20
Hercules Capital has a rich history of dividend payments and outperforming the competition. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2023
Via Benzinga
The 3 Most Promising Pharma Stocks to Own Now
A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride. 
Via InvestorPlace
When A Secondary Stock Offering Is Great News
A secondary stock offering comes with a sharp drop in a company’s stock price. Rapid price declines make investors nervous, wondering if the company is facing troubles. 
Via Talk Markets
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
RingCentral, Alteryx, International Flavors & Fragrances And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows: 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.